These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy. Morris HR; Schrag A; Nath U; Burn D; Quinn NP; Daniel S; Wood NW; Lees AJ Neurosci Lett; 2001 Oct; 312(2):118-20. PubMed ID: 11595348 [TBL] [Abstract][Full Text] [Related]
9. Concomitant progressive supranuclear palsy and multiple system atrophy: more than a simple twist of fate? Silveira-Moriyama L; González AM; O'Sullivan SS; Williams DR; Massey L; Parkkinen L; Ahmed Z; de Silva R; Chacón JR; Revesz T; Lees AJ; Holton JL Neurosci Lett; 2009 Dec; 467(3):208-11. PubMed ID: 19835934 [TBL] [Abstract][Full Text] [Related]
10. [Progressive supranuclear palsy; an unusual form of parkinsonism]. Donker Kaat L; Boon AJ; Heutink P; van Swieten JC Ned Tijdschr Geneeskd; 2004 Mar; 148(11):519-23. PubMed ID: 15054950 [TBL] [Abstract][Full Text] [Related]
13. Neuropathology of variants of progressive supranuclear palsy. Dickson DW; Ahmed Z; Algom AA; Tsuboi Y; Josephs KA Curr Opin Neurol; 2010 Aug; 23(4):394-400. PubMed ID: 20610990 [TBL] [Abstract][Full Text] [Related]
14. The diagnosis of progressive supranuclear palsy: current opinions and challenges. Ali F; Josephs K Expert Rev Neurother; 2018 Jul; 18(7):603-616. PubMed ID: 29902389 [TBL] [Abstract][Full Text] [Related]
15. Progressive supranuclear palsy: clinical and genetic aspects. Pastor P; Tolosa E Curr Opin Neurol; 2002 Aug; 15(4):429-37. PubMed ID: 12151839 [TBL] [Abstract][Full Text] [Related]
16. Unexpected abundance of pathological tau in progressive supranuclear palsy white matter. Zhukareva V; Joyce S; Schuck T; Van Deerlin V; Hurtig H; Albin R; Gilman S; Chin S; Miller B; Trojanowski JQ; Lee VM Ann Neurol; 2006 Sep; 60(3):335-45. PubMed ID: 16823854 [TBL] [Abstract][Full Text] [Related]
17. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857 [TBL] [Abstract][Full Text] [Related]
18. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Williams DR; Lees AJ Lancet Neurol; 2009 Mar; 8(3):270-9. PubMed ID: 19233037 [TBL] [Abstract][Full Text] [Related]
19. Tau genotype: no effect on onset, symptom severity, or survival in progressive supranuclear palsy. Litvan I; Baker M; Hutton M Neurology; 2001 Jul; 57(1):138-40. PubMed ID: 11445645 [TBL] [Abstract][Full Text] [Related]